Search Results

Search by objective public record fields.

Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.

ClinicalTrials.gov public records Last synced May 22, 2026, 2:45 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–3 of 3 matching trials from the live ClinicalTrials.gov search.

Local D1 index available.

Filters: Condition: Multiple Gestation; Maternal Care Clear all

Completed Not applicable Interventional

Family Nurture Intervention in the NICU

NCT02710474

View directory record Official record

Conditions: Premature Birth, Obstetric Labor, Premature
Interventions: Family Nurture Intervention, Standard Care; Behavioral
Lead sponsor: Columbia University; Other
Eligibility: 26 Weeks to 34 Weeks

Enrollment: 461 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 2
States / cities: New York, New York • San Antonio, Texas

Source: ClinicalTrials.gov public record

Updated Feb 14, 2023 · Synced May 22, 2026, 2:45 AM EDT

Completed No phase listed Observational

Clinical Utility of the Addition of a SNP-based NIPT Zygosity Determination in Twin Pregnancy Management.

NCT05312814

View directory record Official record

Conditions: Twin to Twin Transfusion Syndrome, Pregnancy Complications, Multiple Gestation; Maternal Care
Interventions: Not listed
Lead sponsor: Natera, Inc.; Industry
Eligibility: 18 Years to 55 Years · Female only

Enrollment: 137 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 8
States / cities: San Diego, California • Aurora, Colorado • Annapolis, Maryland + 5 more

Source: ClinicalTrials.gov public record

Updated Sep 25, 2024 · Synced May 22, 2026, 2:45 AM EDT

Recruiting Not applicable Interventional

Pivotal, Prospective, Multi-centre, Single-arm Study to Evaluate the Safety and Effectiveness of Oli for Identification of Patients, During the Intrapartum Period, Who Are at Higher Risk of Developing Abnormal Postpartum Uterine Bleeding, Including Postpartum Haemorrhage

NCT06655207

View directory record Official record

Conditions: Post Partum Haemorrhage, Maternal Care Patterns, High Risk Pregnancy
Interventions: Oli is a non-invasive, wearable device, designed to provide clinicians with an early indication if the participant is at a higher risk of developing abnormal postpartum uterine bleeding; Device
Lead sponsor: Baymatob Operations Pty Ltd; Industry
Eligibility: 18 Years and older · Female only

Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 5
States / cities: Denver, Colorado • Baton Rouge, Louisiana • New York, New York + 2 more

Source: ClinicalTrials.gov public record

Updated Aug 7, 2025 · Synced May 22, 2026, 2:45 AM EDT